Literature DB >> 23903551

Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy.

Alice S Weissfeld1, Riya Augustin Joseph, Theresa V Le, Ernest A Trevino, M Frances Schaeffer, Paula H Vance.   

Abstract

Current guidelines for air sampling for bacteria and fungi in compounding pharmacies require the use of a medium for each type of organism. U.S. Pharmacopeia (USP) chapter <797> (http://www.pbm.va.gov/linksotherresources/docs/USP797PharmaceuticalCompoundingSterileCompounding.pdf) calls for tryptic soy agar with polysorbate and lecithin (TSApl) for bacteria and malt extract agar (MEA) for fungi. In contrast, the Controlled Environment Testing Association (CETA), the professional organization for individuals who certify hoods and clean rooms, states in its 2012 certification application guide (http://www.cetainternational.org/reference/CAG-009v3.pdf?sid=1267) that a single-plate method is acceptable, implying that it is not always necessary to use an additional medium specifically for fungi. In this study, we reviewed 5.5 years of data from our laboratory to determine the utility of TSApl versus yeast malt extract agar (YMEA) for the isolation of fungi. Our findings, from 2,073 air samples obtained from compounding pharmacies, demonstrated that the YMEA yielded >2.5 times more fungal isolates than TSApl.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23903551      PMCID: PMC3811631          DOI: 10.1128/JCM.00944-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacy.

Authors:  Rachel Civen; Duc J Vugia; Richard Alexander; Wendel Brunner; Sirlura Taylor; Nancy Parris; R Wasserman; Sharon Abbott; S B Werner; Jon Rosenberg
Journal:  Clin Infect Dis       Date:  2006-08-22       Impact factor: 9.079

2.  An outbreak of Pantoea spp. in a neonatal intensive care unit secondary to contaminated parenteral nutrition.

Authors:  H Habsah; M Zeehaida; H Van Rostenberghe; R Noraida; W I Wan Pauzi; I Fatimah; A R Rosliza; N Y Nik Sharimah; H Maimunah
Journal:  J Hosp Infect       Date:  2005-11       Impact factor: 3.926

3.  Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state.

Authors:  Melissa R Held; Elizabeth M Begier; Diana S Beardsley; Frederick A Browne; Richard A Martinello; Robert S Baltimore; L Clifford McDonald; Bette Jensen; James L Hadler; Louise-Marie Dembry
Journal:  Pediatrics       Date:  2006-06-19       Impact factor: 7.124

4.  Preventing blood contamination in nuclear pharmacies: lessons from an outbreak of hepatitis C virus infections and contaminated 99mTc-sestamibi.

Authors:  Priti R Patel; Joseph F Perz; Anthony E Fiore; Amanda D Castel
Journal:  J Nucl Med       Date:  2007-11       Impact factor: 10.057

5.  Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy.

Authors:  Joseph F Perz; Allen S Craig; Charles W Stratton; Stanley J Bodner; Walter E Phillips; William Schaffner
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications--Brazil, 1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-07-31       Impact factor: 17.586

7.  Pseudomonas bloodstream infections associated with a heparin/saline flush--Missouri, New York, Texas, and Michigan, 2004-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-03-25       Impact factor: 17.586

8.  Fungal infections associated with contaminated methylprednisolone injections.

Authors:  Rachel M Smith; Melissa K Schaefer; Marion A Kainer; Matthew Wise; Jennie Finks; Joan Duwve; Elizabeth Fontaine; Alvina Chu; Barbara Carothers; Amy Reilly; Jay Fiedler; Andrew D Wiese; Christine Feaster; Lex Gibson; Stephanie Griese; Anne Purfield; Angela A Cleveland; Kaitlin Benedict; Julie R Harris; Mary E Brandt; Dianna Blau; John Jernigan; J Todd Weber; Benjamin J Park
Journal:  N Engl J Med       Date:  2012-12-19       Impact factor: 91.245

9.  Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-12-13       Impact factor: 17.586

10.  A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.

Authors:  Rebecca H Sunenshine; Esther T Tan; Dawn M Terashita; Bette J Jensen; Marilyn A Kacica; Emily E Sickbert-Bennett; Judith A Noble-Wang; Michael J Palmieri; Dianna J Bopp; Daniel B Jernigan; Sophia Kazakova; Eddy A Bresnitz; Christina G Tan; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2007-07-24       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.